Copyright 2009 Medical News Today Latest Prostate / Prostate Cancer News From Medical News Today. http://www.medicalnewstoday.com/sections/prostate/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Tue, 10 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170339.php http://www.medicalnewstoday.com/articles/170339.php In the November 2009 issue of the Journal of Urology, Stanford Medical School researcher Dr. Rodney Anderson and researchers at the National Center for Pelvic Pain Research, in a new study, demonstrated a high correlation between the location of painful trigger points inside the pelvic floor muscles of men with chronic prostatitis and the location in the body where they routinely complain of pain. Urology / Nephrology Sat, 07 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170195.php http://www.medicalnewstoday.com/articles/170195.php Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy. Elevated levels of PSA have traditionally been seen as a potential sign of prostate cancer, leading to the widespread use of PSA testing. Prostate / Prostate Cancer Fri, 06 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170143.php http://www.medicalnewstoday.com/articles/170143.php Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. HIV / AIDS Fri, 06 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170051.php http://www.medicalnewstoday.com/articles/170051.php The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer detection. It is argued that a rapidly rising PSA may indicate a greater risk of diagnosis of prostate cancer even if PSA levels are low. Prostate / Prostate Cancer Thu, 05 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169983.php http://www.medicalnewstoday.com/articles/169983.php Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival. Their findings were presented this week at the 51st annual meeting of the American Society of Therapeutic Radiology and Oncology in Chicago. Prostate / Prostate Cancer Thu, 05 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/169933.php http://www.medicalnewstoday.com/articles/169933.php Men who have used 'Simplicity Health' or 'Fortel' home testing kits for prostate cancer screening during the past 12 months are being urged to contact their GP for advice. This follows recent notification to the Medicines and Healthcare products Regulatory Agency (MHRA) that the two kits from batch number 1012 are faulty and could give a false negative result. The 1000 defective devices shipped to the UK were sold through pharmacies and via the internet. Prostate / Prostate Cancer Thu, 05 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/169939.php http://www.medicalnewstoday.com/articles/169939.php A patient's socioeconomic status (income, marital status and race) has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a new study from Henry Ford Hospital in Detroit. "This study offers an extremely important message for all patients with prostate cancer who receive radiation therapy," says Benjamin Movsas, M.D. Prostate / Prostate Cancer Thu, 05 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/169941.php http://www.medicalnewstoday.com/articles/169941.php Men whose prostate specific antigen (PSA) rise within 18 months of radiotherapy are more likely to develop spread and die of their disease, according to an international study led by Fox Chase Cancer Center radiation oncologist Mark K. Buyyounouski, M.D., M.S. and presented at the annual meeting of the American Society for Radiation Oncology (ASTRO). "PSA is the gold standard for following prostate cancer patients after they receive radiation or surgery. Prostate / Prostate Cancer Thu, 05 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/169846.php http://www.medicalnewstoday.com/articles/169846.php A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed? The answer may lie in the size and shape of the blood vessels that are visible within the cancer, according to research led by investigators at The Ohio State University Comprehensive Cancer Center-Arthur G. Prostate / Prostate Cancer Wed, 04 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169780.php http://www.medicalnewstoday.com/articles/169780.php Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study. In a prospective study of more than 5,000 U.S. men, epidemiologists say they now have evidence that having lower levels of heart-clogging fat may cut a man's risk of this form of cancer by nearly 60 percent. Prostate / Prostate Cancer Wed, 04 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169774.php http://www.medicalnewstoday.com/articles/169774.php A pair of studies in Cancer Epidemiology, Biomarkers & Prevention, lay to rest the decades-long concern that lower total cholesterol may lead to cancer, and in fact lower cholesterol may reduce the risk of high-grade prostate cancer. Demetrius Albanes, M.D., a senior investigator at the National Cancer Institute, said early studies suggested that low cholesterol could increase the risk of certain types of cancer. Cholesterol Wed, 04 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/169822.php http://www.medicalnewstoday.com/articles/169822.php Two new studies from the US published this week negate concerns that have been around since early studies done decades ago suggested that low cholesterol leads to some types of cancer: one in fact affirms that undiagnosed cancer is the likely cause of lower total cholesterol while the other found evidence linking low cholesterol and decreased risk of high-grade prostate cancer among older men. Cholesterol Wed, 04 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/169741.php http://www.medicalnewstoday.com/articles/169741.php A shorter, five-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears to be just as effective and as safe in reducing the risk of prostate cancer from returning as standard radiation therapy, yet is delivered in two-and-a-half weeks less time, according to interim results of a randomized study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO). Prostate / Prostate Cancer Tue, 03 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169635.php http://www.medicalnewstoday.com/articles/169635.php Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured. The data was presented at the annual meeting of the American Society for Radiation Oncology. Prostate / Prostate Cancer Tue, 03 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169638.php http://www.medicalnewstoday.com/articles/169638.php Proton beam therapy can be safely delivered to men with prostate cancer and has minimal urinary and rectal side effects, according to a study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago. Prostate / Prostate Cancer Tue, 03 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169641.php http://www.medicalnewstoday.com/articles/169641.php Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago. Prostate / Prostate Cancer Tue, 03 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169649.php http://www.medicalnewstoday.com/articles/169649.php Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone, according to a Radiation Therapy Oncology Group (RTOG) study, the largest randomized trial of its kind, presented November 2, 2009, at the American Society for Radiation Oncology (ASTRO) annual meeting. Prostate / Prostate Cancer Tue, 03 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/169533.php http://www.medicalnewstoday.com/articles/169533.php Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients, according to the largest randomized study of its kind presented at the plenary session November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO). Prostate / Prostate Cancer Mon, 02 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169496.php http://www.medicalnewstoday.com/articles/169496.php Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies. The data are being presented at the International Society for Biological Therapy of Cancer 2009 Annual Meeting. Melanoma / Skin Cancer Mon, 02 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/169440.php http://www.medicalnewstoday.com/articles/169440.php UroToday.com - This was an open label single institution study that looked at the activity and toxicity of single agent erlotinib in patients with CRPC who have not received chemotherapy yet. The mechanisms by which prostate cancer becomes castration resistant are variable and multiple. One hypothesis is that the overexpression of the epidermal growth factor receptor (EGFR) allows for downstream cell signaling causing cancer cell growth and proliferation. Prostate / Prostate Cancer Mon, 02 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/169449.php http://www.medicalnewstoday.com/articles/169449.php The Asian continent has nearly four billion people living in 47 different countries, and each of these groups has their own unique set of health issues. But when they come to the United States, they're often lumped into one large demographic: "Asian/Pacific Islander." Health researchers say this makes it difficult to learn about each group's specific needs, particularly in regard to cancer, one of the leading killers of Asian-Americans. Cancer / Oncology Sun, 01 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/169408.php http://www.medicalnewstoday.com/articles/169408.php UroToday.com - In the online edition of the Journal of Clinical Oncology, Dr. Douglas McNeel and associates report a phase I/IIa trial of a DNA vaccine encoding prostatic acid phosphatase (PAP) in patients with stage D0 prostate cancer (CaP). PAP is a prostate tumor antigen that can elicit an immunologic antigen-specific CD8+ T cell response. The vaccine, pTVG-HP, is a plasmid DNA encoding the full length human PAP cDNA downstream of a eukaryotic promoter. Prostate / Prostate Cancer Sun, 01 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/169399.php http://www.medicalnewstoday.com/articles/169399.php UroToday.com - In the online edition of the Journal of Clinical Oncology, a multi-institutional study reports on prostate cancer (CaP)-specific mortality after radical prostatectomy (RP) treated since the introduction of PSA. The study sought to establish a predictive nomogram and modeled the nomogram on 6,398 patients treated with RP at Baylor and MSKCC between 1987 and 2005. Prostate / Prostate Cancer Sat, 31 Oct 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169398.php http://www.medicalnewstoday.com/articles/169398.php UroToday.com - An article in the online edition of Cancer assesses differences in prostate cancer (CaP) treatment, trust and regular patient care based upon patient race. The North Carolina-Louisiana prostate Cancer Project (PCaP) is a population-based study of men identified shortly after CaP diagnosis. Enrollment began in 2004, however there was a temporary study enrollment lapse in Louisiana due to Hurricane Katrina. Prostate / Prostate Cancer Fri, 30 Oct 2009 07:00:00 PST http://www.medicalnewstoday.com/articles/169361.php http://www.medicalnewstoday.com/articles/169361.php Researchers in the US have discovered that the male hormone androgen may trigger the gene fusion that leads to the development of prostate cancer: they found that pieces of chromosome that normally sit far apart, relocate near each other after exposure to androgen, and this sets the scene for the genes to fuse. Prostate / Prostate Cancer